Massachusetts’s attorney general sued Johnson & Johnson’s Ortho-McNeil-Janssen unit for improper marketing of the anti-psychotic drug Risperdal. The company marketed the drug as a treatment for dementia in the elderly and a way to ease various ailments of younger people when those uses hadn’t been approved by the U.S. Food and Drug Administration, Attorney General Martha Coakley said today in a statement.
Johnson & Johnson’s promotion of Risperdal for dementia failed to disclose “an increased risk of death” associated with the drug, according to the statement. The FDA approved the medication primarily for treating schizophrenia and bipolar mood disorder, according to Coakley’s office.
“Janssen’s illegal marketing and sales tactics helped the company generate hundreds of millions of dollars in sales in the Commonwealth,” the complaint states…
Piling on? No sir! Janssen/J&J wants to settle all these suits for $1 B total. They’re making that in yearly profit even out of patent. The TMAP story and its derivatives in other States were an affront to our form of government and the governed – racketeering using paid physicians who were employed by the government they were bilko-ing. They ought to go to prison for fraud and the financial penalty really should fit the crime [putting Janssen out of business and jailing the executives/physicians would be just fine with me]. They earned it fair and square. If they settle, they need to settle for their whole profit at the least – the kind of the thing that would be felt by every J&J shareholder and everyone involved in concocting this macabre scheme. Shameful corporate behavior. And Janssen wasn’t the only pharmaceutical company involved [AstraZeneca, Eli Lilly, etc.], just the leader of the pack…
Sorry, the comment form is closed at this time.